Furthermore, our observation that miR-21 mediated PTEN-Akt signaling could be normalized by CDF in chemo-resistant colon cancer cells suggests that CDF could be a potential therapeutic agent for recurrent colon cancer. The gene discussed is PTEN; the disease is colonic neoplasm.